NCT05360680 2026-01-22A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic CancersCue BiopharmaPhase 1 Completed42 enrolled
NCT03311334 2024-04-18A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid TumorsSumitomo Pharma America, Inc.Phase 1/2 Terminated47 enrolled 11 charts
NCT02498665 2023-11-14A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced MalignanciesSumitomo Pharma America, Inc.Phase 1 Completed24 enrolled